April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
18 Months Outcomes Of 4 Ns Duration Selective Laser Trabeculoplasty In Open-angle Glaucoma And Ocular Hypertension Patients
Author Affiliations & Notes
  • Paolo Frezzotti
    Ophthalmology, University of Siena, Siena, Italy
  • Ilaria Motolese
    Ophthalmology, University of Siena, Siena, Italy
  • Sabrina Peruzzi
    Ophthalmology, University of Siena, Siena, Italy
  • Pietro Mittica
    Ophthalmology, University of Siena, Siena, Italy
  • Simone Alex Bagaglia
    Ophthalmology, University of Siena, Siena, Italy
  • Eduardo Motolese
    Ophthalmology, University of Siena, Siena, Italy
  • Footnotes
    Commercial Relationships  Paolo Frezzotti, None; Ilaria Motolese, None; Sabrina Peruzzi, None; Pietro Mittica, None; Simone Alex Bagaglia, None; Eduardo Motolese, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2612. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Paolo Frezzotti, Ilaria Motolese, Sabrina Peruzzi, Pietro Mittica, Simone Alex Bagaglia, Eduardo Motolese; 18 Months Outcomes Of 4 Ns Duration Selective Laser Trabeculoplasty In Open-angle Glaucoma And Ocular Hypertension Patients. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2612.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Selective laser trabeculoplasty (SLT) is a treatment for open angle glaucoma. The purpose of this study was to examine whether a new Q switched Nd-Yag laser with a pulse duration of 4 ns provides clinical benefit for uncrontrolled open-angle glaucoma and ocular hypertension patients

Methods: : 156 eyes of 150 patients with uncontrolled open angle glaucoma and ocular hypertension were enrolled in this prospective non-randomized study and they were treated with selective laser trabeculoplasty. All patients underwent complete ophthalmic evaluation before and at intervals after treatment. This evaluation included visual acuity, slit lamp examination, ophthalmoscopy, gonioscopy and visual field analysis. The IOP was measured 1 day and 1,3,6,9,12 and 18 months postoperatively. During the follow-up period patients were treated with topical antiglaucoma medications as required

Results: : Intraocular pressure before treatment was 20.04 + 3.3 mmHg, one day after the treatment IOP was 18.43 + 3.1 mmHg (P= 0.002), 1 month after the treatment was 15.7 mmHg + 2.9 mmHg (P< 0.001), 3 months after the treatment was 15.7 mmHg + 2.3 mmHg (P< 0.001), after six months intraocular pressure was 15.7 mmHg + 2.3 mmHg (P< 0.001), after 12 months intraocular pressure reduction was 21 % (P< 0.001), and 18 months it was 21.3% (P< 0.001). The energy released during treatment was 65 + 22 mJ. In the first day after the treatment, the percentage of discomfort "absent" was in 98.8% of patients. Absence of flare and cellularity in the anterior chamber was 100% on the first day and at the last follow-up visit.

Conclusions: : SLT with a pulse duration of 4 ns is a safe and effective procedure to reduce IOP in uncontrolled open angle glaucoma patients

Keywords: laser • intraocular pressure • outflow: trabecular meshwork 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×